Deciding What to Commercialize in Microbial Biologics to Ensure Successful Products & Less Wasted Resources

• Evaluating scientific credibility, field relevance, and customer trust as go and/or no-go criteria
• Applying early microbiome analysis to focus development on products that work under real grower conditions
• Balancing innovation with commercial risk when choosing what moves from R&D into product pipelines

Speakers:

Sarah Reiter

Senior Vice President, Business Development

BioConsortia